A joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine on standardising the biochemical confirmation of adult male hypogonadism.

Joint safety alert from the British Menopause Society, Faculty of Sexual & Reproductive Healthcare, Royal College of General Practitioners, Royal College of Obstetricians & Gynaecologists, Society for Endocrinology and the Royal College of Nursing Women’s Health Forum.
 
This safety alert has been produced in response to questions raised in relation to appropriate doses of oestrogen and progestogen provided to women experiencing symptoms of menopause.

Read the alert in full.

Both the Association of British Clinical Diabetologists & Society for Endocrinology recommend that Endocrinology & Diabetes specialty training must include a minimum of two years (or equivalent) of protected specialty time, with no IM commitment during this time. (April 2019)

A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. (February 2019)

This document explains how the wide range of endocrine conditions are best diagnosed and managed by teams of doctors working in a variety of different clinical settings. (October 2011 under review)

This statement advises on the use of Synacthen in patients with a history of asthma. (2020)

The Society endorses this position statement, written by the British Thyroid Association Executive Committee in 2015, for the management of primary hypothyroidism. (September 2015
under review)

This position statement highlights the suppressive effects of inhaled corticosteroids on the endogenous hypothalamo-pituitary-adrenal axis. (2020)

This statement outlines key points in the perioperative management of patients with PPGL. (October 2010 updated 2017)